Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Myelodysplastic Syndromes 361Leukemia, Myeloid, Acute 302Myeloproliferative Disorders 155Leukemia, Myelogenous, Chronic, BCR-ABL Positive 142Precursor Cell Lymphoblastic Leukemia-Lymphoma 115Primary Myelofibrosis 103Leukemia, Myelomonocytic, Chronic 89Lymphoma, Non-Hodgkin 76Leukemia 71Polycythemia Vera 64Multiple Myeloma 55Hodgkin Disease 50Hematologic Neoplasms 49Leukemia, Lymphocytic, Chronic, B-Cell 44Leukemia, Biphenotypic, Acute 41Thrombocythemia, Essential 40Lymphoma 40Myelodysplastic-Myeloproliferative Diseases 32Neoplasms 29Leukemia, Myeloid, Chronic-Phase 28Anemia, Refractory, with Excess of Blasts 24Recurrence 23Anemia, Aplastic 21Lymphoma, Mantle-Cell 20Lymphoma, Follicular 20Hematologic Diseases 20Burkitt Lymphoma 20Blastic Plasmacytoid Dendritic Cell Neoplasm 20Blast Crisis 20Histiocytosis, Langerhans-Cell 19

Interventions

decitabine and cedazuridine drug combination 1avapritinib 1Decitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Systemic Mastocytosis With an Associated Hematologic Neoplasm × Myeloid × 1 year × Clear all
NCT06327685 2026-04-01

Avapritinib With Decitabine in Patients With SM-AHN

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Recruiting
34 enrolled
MyeloidOther hematologic neoplasm

Systemic Mastocytosis With an Associated Hematologic Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡